Research

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood cancer, thanks to the fundamental support of the “la Caixa” Foundation.

From left to right: Mr. Àngel Font, Dr. Josep M. Campistol, Dr. Carlos Fernández de Larrea, Mr. Joan Gel, Dr. Julio Delgado, Dr. Manel Juan (Picture: Francisco Avia – Hospital Clínic)

Related contents